SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000929638-23-003066
Filing Date
2023-11-09
Accepted
2023-11-09 17:25:56
Documents
17
Period of Report
2023-11-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT a8k.htm   iXBRL 8-K 43144
2 exhibit10-1.htm EX-10.1 77086
3 exhibit10-2.htm EX-10.2 77112
4 exhibit10-3.htm EX-10.3 77965
5 exhibit10-4.htm EX-10.4 65025
  Complete submission text file 0000929638-23-003066.txt   592585

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA engn-20231108.xsd EX-101.SCH 4591
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE engn-20231108_def.xml EX-101.DEF 18194
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE engn-20231108_lab.xml EX-101.LAB 28281
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE engn-20231108_pre.xml EX-101.PRE 20436
11 EXTRACTED XBRL INSTANCE DOCUMENT a8k_htm.xml XML 6478
Mailing Address 7171 RUE FREDERICK BANTING SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 RUE FREDERICK BANTING SAINT-LAURENT A8 H4S 1Z9 (514) 332-4888
enGene Holdings Inc. (Filer) CIK: 0001980845 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1031
Type: 8-K | Act: 34 | File No.: 001-41854 | Film No.: 231393901
SIC: 2836 Biological Products, (No Diagnostic Substances)